Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
Abstract Background The most common biomarkers of Alzheimer’s disease (AD) are amyloid β (Aβ) and tau, detected in cerebrospinal fluid (CSF) or with positron emission tomography imaging. However, these procedures are invasive and expensive, which hamper their availability to the general population....
Guardado en:
Autores principales: | Longfei Jia, Min Zhu, Jianwei Yang, Yana Pang, Qi Wang, Ying Li, Tingting Li, Fangyu Li, Qigeng Wang, Yan Li, Yiping Wei |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1a5ed875f62646dea79fa1c3a91d7bad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploratory Profiling of Extracellular MicroRNAs in Cerebrospinal Fluid Comparing Leptomeningeal Metastasis with Other Central Nervous System Tumor Statuses
por: Ji Hye Im, et al.
Publicado: (2021) -
MicroRNAs: Marcadores séricos en diabetes mellitus tipo 2 y ejercicio físico
por: Gómez-Banoy,Nicolás, et al.
Publicado: (2016) -
MicroRNA-27b Expression in Rats Submitted to Physical Exercise and Experimental Cerebral Ischemia
por: De-Russi,Brenno Marco, et al.
Publicado: (2021) -
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021) -
Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
por: Yanyan Jiang, et al.
Publicado: (2021)